ω-3 Fatty Acid Ethyl Esters Diminish Postprandial Lipemia in Familial Hypercholesterolemia
- PMID: 27490922
- DOI: 10.1210/jc.2016-2217
ω-3 Fatty Acid Ethyl Esters Diminish Postprandial Lipemia in Familial Hypercholesterolemia
Abstract
Context: Impaired postprandial chylomicron metabolism induces hypertriglyceridemia and may increase the risk of atherosclerotic cardiovascular disease. Omega-3 fatty acid ethyl ester (ω-3 FAEE) supplementation decreases plasma triglycerides. However, its effect on postprandial chylomicron metabolism in familial hypercholesterolemia (FH) has not yet been investigated.
Objective: We aimed to examine the effect of ω-3 FAEE supplementation on postprandial responses in plasma triglycerides, very-low-density lipoprotein (VLDL) apolipoprotein B (apoB)-100, and apoB-48 in FH patients receiving standard cholesterol-lowering treatment.
Design, setting, and patients: We carried out an 8-week open-label, randomized, crossover intervention trial to test the effect of oral supplementation with 4 g/d ω-3 FAEE (46% eicosapentaenoic acid and 38% docosahexaenoic acid) on postprandial triglyceride, VLDL-apoB-100, and apoB-48 responses in FH patients after ingestion of an oral fat load.
Outcomes measures: Plasma total and incremental triglyceride, VLDL-apoB-100, and apoB-48 0- to 10-hour area under the curve (AUC).
Results: ω-3 FAEE supplementation significantly (P < .05 in all) reduced concentrations of fasting plasma triglyceride (-20%), apoB (-8%), VLDL-apoB-100 (-26%), and apoB-48 (-36%); as well as systolic blood pressure (-6%) and diastolic blood pressure (-6%). Postprandial triglyceride and VLDL-apoB-100 total AUCs (-19% and -26%, respectively; P < .01) and incremental AUCs (-18% and -35%, respectively; P < .05), as well as postprandial apoB-48 total AUC (-30%; P < .02) were significantly reduced by ω-3 FAEE supplementation.
Conclusion: Supplementation with ω-3 FAEEs improves postprandial lipemia in FH patients receiving standard care; this may have implications for further reducing atherosclerotic cardiovascular disease in this high-risk patient group.
Trial registration: ClinicalTrials.gov NCT01577056.
Similar articles
-
Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.Lipids Health Dis. 2017 Aug 10;16(1):149. doi: 10.1186/s12944-017-0541-3. Lipids Health Dis. 2017. PMID: 28797250 Free PMC article. Review.
-
Effect of omega-3 fatty acid supplementation on arterial elasticity in patients with familial hypercholesterolaemia on statin therapy.Nutr Metab Cardiovasc Dis. 2016 Dec;26(12):1140-1145. doi: 10.1016/j.numecd.2016.07.012. Epub 2016 Aug 3. Nutr Metab Cardiovasc Dis. 2016. PMID: 27614801 Clinical Trial.
-
n-3 Polyunsaturated Fatty Acid Supplementation Has No Effect on Postprandial Triglyceride-Rich Lipoprotein Kinetics in Men with Type 2 Diabetes.J Diabetes Res. 2016;2016:2909210. doi: 10.1155/2016/2909210. Epub 2016 Feb 29. J Diabetes Res. 2016. PMID: 27034958 Free PMC article. Clinical Trial.
-
Effect of ω-3 fatty acid ethyl esters on apolipoprotein B-48 kinetics in obese subjects on a weight-loss diet: a new tracer kinetic study in the postprandial state.J Clin Endocrinol Metab. 2014 Aug;99(8):E1427-35. doi: 10.1210/jc.2013-4037. Epub 2014 Feb 27. J Clin Endocrinol Metab. 2014. PMID: 24606094 Clinical Trial.
-
Dietary fat and postprandial lipids.Curr Atheroscler Rep. 2003 Nov;5(6):445-51. doi: 10.1007/s11883-003-0034-x. Curr Atheroscler Rep. 2003. PMID: 14525677 Review.
Cited by
-
Current Evidence and Future Directions of Omega-3 Supplementation and Cardiovascular Disease Risk.Int J Angiol. 2023 Nov 24;33(1):1-7. doi: 10.1055/s-0043-1777258. eCollection 2024 Feb. Int J Angiol. 2023. PMID: 38352637 Review.
-
Does fish oil supplementation increase cholesterol efflux capacity in familial hypercholesterolaemia?Eur J Clin Invest. 2023 Oct;53(10):e14048. doi: 10.1111/eci.14048. Epub 2023 Jun 29. Eur J Clin Invest. 2023. PMID: 37386840 Free PMC article. No abstract available.
-
Effect of N-3 Polyunsaturated Fatty Acids on Lipid Composition in Familial Hypercholesterolemia: A Randomized Crossover Trial.Biomedicines. 2022 Jul 27;10(8):1809. doi: 10.3390/biomedicines10081809. Biomedicines. 2022. PMID: 36009356 Free PMC article.
-
Effect of Omega-3 Fatty Acid Supplementation on the Postprandial Metabolism of Apolipoprotein(a) in Familial Hypercholesterolemia.J Atheroscler Thromb. 2023 Mar 1;30(3):274-286. doi: 10.5551/jat.63587. Epub 2022 Jun 8. J Atheroscler Thromb. 2023. PMID: 35676030 Free PMC article. Clinical Trial.
-
The Effect of Dietary Interventions on Hypertriglyceridemia: From Public Health to Molecular Nutrition Evidence.Nutrients. 2022 Mar 5;14(5):1104. doi: 10.3390/nu14051104. Nutrients. 2022. PMID: 35268076 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous